EUVIMEDEUVIMED entdecken
Open Access

Simultaneous Targeting of Tumor Cells and Tumor-Associated Macrophages To Reprogram Glioblastoma Using Trypsinized Extracellular Vesicles Carrying Tumor Suppressive MicroRNA

Grace H Nguyen, MinHye Noh, Jin Muk Kang, Alexandra A Miller, Minxin Huang, Jiyeon Kim iD, Jeong-Yeon Lee, Sangwoon Chung, Hongyu Wang, George A Calin, Cynthia Ju, Holger K Eltzschig und 4 weitere

Nano Letters · 2025

DOI: 10.1021/acs.nanolett.5c01897 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Letters, 2025. Verfasst von Grace H Nguyen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, McGovern Medical School, University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, Texas 77030, …. Hauptthemen laut MEDLINE: Glioblastoma, MicroRNAs, Extracellular Vesicles, Tumor-Associated Macrophages. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NINDS NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) remains difficult to treat due to poor drug delivery across the blood-brain barrier and an immunosuppressive tumor microenvironment (TME). Tumor-suppressive microRNAs (miRNAs) offer a promising strategy to reprogram both tumor cells and the TME, but inefficient delivery systems limit their clinical application. We previously reported that tumor-suppressive miR-138 regresses tumor growth in preclinical GBM models. Here, we demonstrate that trypsin digestion of extracellular vesicles (EVs) enhances labeling efficiency with folate (FA), enhancing selective targeting of folate receptor (FR)-positive GBM cells and enabling simultaneous targeting of tumor-associated macrophages (TAMs). FA-labeled trypsinized EVs (tEVs) loaded with miR-138 inhibit tumor growth, depolarize TAMs, and enhance antitumor immunity. This study represents the first preclinical attempt to modulate tumor cells and innate immunity via miRNA-loaded tEVs, offering a novel and more effective therapeutic approach to GBM treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaMicroRNAsExtracellular VesiclesTumor-Associated MacrophagesBrain NeoplasmsHumansTumor MicroenvironmentAnimalsMiceCell Line, TumorFolic Acid

Stichwörter der Autor:innen

Extracellular vesicle (EV)Glioblastoma (GBM)TrypsinTumor microenvironment (TME)Tumor-associated macrophages (TAMs)microRNA-138 (miR-138)

Substanzen

MicroRNAsFolic Acid

Autor:innen und Institutionen

  • Department of Neurosurgery, McGovern Medical School, University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, Texas 77030, United States.
  • Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center-UT Health at Houston, 6767 Bertner Avenue, Houston, Texas 77030, United States.
  • Department of Pathology, College of Medicine, Hanyang University, 222 Wangsimni-ro, Seongdong-gu, Seoul 04763, South Korea.
  • Pulmonary, Allergy, Critical Care and Sleep Medicine, The Ohio State University Wexner Medical Center, Davis Heart and Lung Research Institute, 473 W 12th Avenue, Columbus, Ohio 43210, United States.
  • Department of Diagnostic and Interventional Imaging, McGovern Medical School, University of Texas Health Science Center at Houston, 6901 Bertner Avenue, Houston, Texas 77030, United States.
  • Department of Translational Molecular Pathology, Division of Pathology-Lab Medicine, Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 770…

ORCID-Profile: Jiyeon Kim, Tae Jin Lee

Förderung

  • NIDDK NIH HHS
  • NINDS NIH HHS
  • NIGMS NIH HHS
  • NCI NIH HHS
  • NHLBI NIH HHS
  • U.S. Department of Health and Human Services
  • Cancer Prevention and Research Institute of Texas
  • American Cancer Society

Zitieren

APA

Nguyen, G. H., Noh, M., Kang, J. M., Miller, A. A., Huang, M., Kim, J., Lee, J. Y., Chung, S., Wang, H., Calin, G. A., Ju, C., Eltzschig, H. K., Banasavadi-Siddegowda, Y., Zhao, Z., Yoo, J. Y., & Lee, T. J. (2025). Simultaneous Targeting of Tumor Cells and Tumor-Associated Macrophages To Reprogram Glioblastoma Using Trypsinized Extracellular Vesicles Carrying Tumor Suppressive MicroRNA. Nano Letters. https://doi.org/10.1021/acs.nanolett.5c01897

Vancouver

Nguyen GH, Noh M, Kang JM, Miller AA, Huang M, Kim J, et al. Simultaneous Targeting of Tumor Cells and Tumor-Associated Macrophages To Reprogram Glioblastoma Using Trypsinized Extracellular Vesicles Carrying Tumor Suppressive MicroRNA. Nano Letters. 2025. doi:10.1021/acs.nanolett.5c01897

BibTeX
@article{Nguyen2025,
  author = {Nguyen, Grace H and Noh, MinHye and Kang, Jin Muk and Miller, Alexandra A and Huang, Minxin and Kim, Jiyeon and Lee, Jeong-Yeon and Chung, Sangwoon and Wang, Hongyu and Calin, George A and Ju, Cynthia and Eltzschig, Holger K and Banasavadi-Siddegowda, Yeshavanth and Zhao, Zhongming and Yoo, Ji Young and Lee, Tae Jin},
  title = {Simultaneous Targeting of Tumor Cells and Tumor-Associated Macrophages To Reprogram Glioblastoma Using Trypsinized Extracellular Vesicles Carrying Tumor Suppressive MicroRNA},
  journal = {Nano Letters},
  year = {2025},
  doi = {10.1021/acs.nanolett.5c01897}
}
Kostenlos starten →